Intravitreal dexamethasone implant (Ozurdex) and photodynamic therapy for vasoproliferative retinal tumours

Can J Ophthalmol. 2014 Aug;49(4):e83-4. doi: 10.1016/j.jcjo.2014.04.006. Epub 2014 Jul 17.

Authors

Zafer Cebeci¹, Merih Oray², Samuray Tuncer², Ilknur Tugal Tutkun², Nur Kir²

Affiliations

¹ Istanbul University, Istanbul Faculty of Medicine, Ophthalmology Department, Istanbul, Turkey. Electronic address: [email protected].
² Istanbul University, Istanbul Faculty of Medicine, Ophthalmology Department, Istanbul, Turkey.

PMID: 25103664
DOI: 10.1016/j.jcjo.2014.04.006

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Combined Modality Therapy
Dexamethasone / administration & dosage*
Drug Implants
Female
Fluorescein Angiography
Glucocorticoids / administration & dosage*
Humans
Intravitreal Injections
Neoplasms, Vascular Tissue / diagnosis
Neoplasms, Vascular Tissue / drug therapy
Neoplasms, Vascular Tissue / surgery
Neoplasms, Vascular Tissue / therapy*
Photochemotherapy*
Retinal Neoplasms / diagnosis
Retinal Neoplasms / drug therapy
Retinal Neoplasms / surgery
Retinal Neoplasms / therapy*
Retinal Neovascularization / diagnosis
Retinal Neovascularization / drug therapy
Retinal Neovascularization / surgery
Retinal Neovascularization / therapy*
Retinal Vessels / pathology
Vitreous Body / drug effects

Substances

Drug Implants
Glucocorticoids
Dexamethasone